Skip to content
Screener

Accounts Payable at other companies

Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$850K+5,100%
Veradermics logo
VeradermicsMANE
$1.07M+256%
GPA
General Purpose Acquisition Corp.GPAC
$8.46M-29.1%
Schering-Plough logo
Schering-PloughSGP
$3.51M+1,045%
Dollar General logo
Dollar GeneralDG
$4.34B+13.2%
Target logo
TargetTGT
$12.19B+3.1%

Other financials

Income statement

See full
Operating income-$84.7M-314%
Net income-$78.9M-339%
EPS (diluted)-$3,650.00+79.7%

Balance sheet

See full
Cash & equivalents$111.8M+9.9%
Total debt$10.5M
Total equity-$432.1M-83.7%
Total assets$624.8M

Cash flow

See full
Operating cash flow-$68.3M-275%

Valuation

See full
Market cap$2.44B-15.8%
Enterprise value$2.34B

Returns & leverage

See full
Debt / equity-0×
Current ratio9.7×

Where this comes from

Reported directly by Kailera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The source filing: Kailera Therapeutics’s 10-Q, filed May 26, 2026. Open the filing →

Filed
May 26, 2026, 4:29 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-239417

FAQ

What is Kailera Therapeutics's accounts payable?
Kailera Therapeutics (KLRA) reported accounts payable of $7.1M in Q1 2026.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Ask your AI about Kailera Therapeutics's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude